Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Pharmacology, Biochemistry, and Behavior|January 1, 1991
Microtubule disruption and cognitive defects: effect of colchicine on learning behavior in ratsG Bensimon, R ChermatThe New England Journal of Medicine|March 3, 1994
A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study GroupG Bensimon, L Lacomblez, V MeiningerLa Revue Du Praticien|April 1, 1991
[Pharmacology of the memory. Review of cognition activator pharmacology]L Lacomblez, G Bensimon, D WarotNeurology|December 1, 1989
A double-blind, placebo-controlled trial of high doses of gangliosides in amyotrophic lateral sclerosisL Lacomblez, P Bouche, G Bensimon, et al.Fundamental & Clinical Pharmacology|January 1, 1987
Comparative effects of zopiclone, triazolam and placebo on memory and psychomotor performance in healthy volunteersD Warot, G Bensimon, P Danjou, et al.Annales De Chirurgie Plastique Et Esthetique|December 30, 2025
Immediate microsurgical breast reconstruction following vertical incision mastectomy in patients with ptotic breasts: An international multicenter case seriesR Laurent, G Bensimon, E Briand, et al.Lancet (London, England)|May 25, 1996
Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group IIL Lacomblez, G Bensimon, P N Leigh, et al.Journal of Neurology|May 22, 2002
A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosisG Bensimon, L Lacomblez, J C Delumeau, et al.British Journal of Clinical Pharmacology|September 1, 1990
Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placeboG Bensimon, J Foret, D Warot, et al.The Journal of Dermatological Treatment|March 18, 2020
An economic evaluation of risankizumab versus other biologic treatments of moderate to severe plaque psoriasis in JapanHidehisa Saeki, Kanako Ishii, Avani Joshi, et al.Pageof 5